CRISPR/Cas9-mediated correction of the sickle mutation in human hematopoietic stem/progenitor cells

Hoban MD, Lumaquin D, Kuo CY, Romero Z, Long J, Ho M, Young CS, Mojadidi M, Fitz-Gibbon S, Cooper AR, Lill GR, Urbinati F, Campo-Fernandez B, Bjurstrom CF, Pellegrini M, Hollis RP, Kohn DB

Friday, July 29, 2016
Published in Molecular Therapy